Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary

Daeun Ryu1,2,3, Seok Jin Kim4, Yourae Hong1

  • 1Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.

Abstract

Insights

Single-cell RNA sequencing reveals that extramedullary multiple myeloma cells exhibit enhanced proliferation and immune evasion mechanisms. These findings in myeloma progression highlight potential therapeutic targets for treatment resistance.

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Extramedullary progression in multiple myeloma is linked to treatment resistance and poor prognosis.
  • Understanding the molecular drivers of myeloma progression is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying extramedullary multiple myeloma progression.
  • To compare the transcriptomes of myeloma cells in the bone marrow versus extramedullary sites using single-cell RNA sequencing.

Main Methods:

  • Single-cell RNA sequencing (RNA-seq) was performed on bone marrow and extramedullary myeloma samples from 15 patients.
  • Transcriptome data from malignant plasma cells and the immune microenvironment were analyzed.

Main Results:

  • Extramedullary myeloma cells showed activated pathways for proliferation, antigen presentation, proteasomes, glycolysis, and oxidative phosphorylation.
  • Myeloma cells displayed autonomous growth potential and expressed immune evasion molecules, including upregulated inhibitory receptors for cytotoxic T and NK cells.
  • The tumor microenvironment contained functionally compromised cytotoxic T lymphocytes and natural killer (NK) cells.

Conclusions:

  • Multiple myeloma cells possess specialized immune evasion strategies within cytotoxic microenvironments.
  • Single-cell transcriptome analysis identified transcriptional programs driving aggressive myeloma progression, supporting autonomous proliferation and immune evasion.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.7K